InflaRx NV (IFRX)
1.38
-0.03
(-2.13%)
USD |
NASDAQ |
May 02, 16:00
1.38
0.00 (0.00%)
Pre-Market: 08:08
InflaRx Free Cash Flow (Quarterly): -11.65M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.65M |
| September 30, 2023 | -5.706M |
| June 30, 2023 | -12.37M |
| March 31, 2023 | -11.30M |
| December 31, 2022 | -7.002M |
| September 30, 2022 | -1.732M |
| June 30, 2022 | -12.58M |
| March 31, 2022 | -14.44M |
| December 31, 2021 | -14.00M |
| September 30, 2021 | -11.27M |
| June 30, 2021 | -9.454M |
| March 31, 2021 | -12.57M |
| December 31, 2020 | -10.38M |
| September 30, 2020 | -11.33M |
| Date | Value |
|---|---|
| June 30, 2020 | -8.466M |
| March 31, 2020 | -11.64M |
| December 31, 2019 | -18.32M |
| September 30, 2019 | -9.101M |
| June 30, 2019 | -11.67M |
| March 31, 2019 | -9.943M |
| December 31, 2018 | -8.057M |
| September 30, 2018 | -4.598M |
| June 30, 2018 | -6.564M |
| March 31, 2018 | -7.179M |
| December 31, 2017 | -3.922M |
| September 30, 2017 | -4.212M |
| June 30, 2017 | -2.864M |
| March 31, 2017 | -2.933M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-18.32M
Minimum
Dec 2019
-1.732M
Maximum
Sep 2022
-10.79M
Average
-11.33M
Median
Sep 2020
Free Cash Flow (Quarterly) Benchmarks
| Affimed NV | -27.55M |
| MorphoSys AG | -- |
| BioNTech SE | 690.54M |
| Immatics NV | 76.06M |
| CureVac NV | -61.17M |